AMPK/mTOR pathway significance in healthy liver and non‐alcoholic fatty liver disease and its progression
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Obesity is related to several organs, but the liver is particularly affected. Adenosine monophosphate‐activated protein kinase (AMPK) is a cellular energy sensor and regulator of liver lipid dysfunction and glucose metabolism. The mechanistic target of rapamycin (mTOR) is a protein kinase regulating cell growth, survival, metabolism, and immunity. Together, these pathways are involved in obesity, insulin resistance, non‐alcoholic fatty liver disease (NAFLD) and its progression, and autophagy. During energy demand, liver kinase B (LKB) phosphorylation helps activate the AMPK/mTOR pathways. Likewise, the protein forkhead box O family (FOXO) negatively regulates adipogenesis by binding to the promoter sites of peroxisome proliferator‐activated receptor‐gamma coactivator 1‐alpha, initiating adipogenesis. In addition, acetyl‐CoA carboxylase, which regulates de novo lipogenesis, is linked to LKB and FOXO in developing NAFLD. The kinase complex, consisting of Unc‐51‐like autophagy‐activating kinase 1 or 2 (ULK1, ULK2) by stimulating autophagy, and eliminating fat droplets in NAFLD, is regulated by mTORC1 and negatively regulated by AMPK that suppresses liver lipogenesis and increases fatty acid oxidation. Also, ULK1 is essential for initiating phagophore formation, establishing macrophagy, and generating autophagosomes. The selective breakdown of lipid droplets through macroautophagy, or macrolipophagy, occurs on a cellular energy level using free fatty acids. In addition, mTORC1 promotes lipogenesis by activating sterol regulatory element‐binding protein. Finding new components and novel regulatory modes in signaling is significant for a better understanding of the AMPK/mTOR pathways, potentially facilitating the development of future diagnostic and therapeutic strategies for NAFLD and its progression to non‐alcoholic steatohepatitis, cirrhosis, and hepatocellular carcinoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Role of Atg Proteins in Autophagosome Formation
Mizushima, N., Yoshimori, T., & Ohsumi, Y. (2011) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-092910-154005 · Cited by 2,978
A mammalian protein targeted by G1-arresting rapamycin–receptor complex
Brown, E. J., Albers, M. W., Bum Shin, T., ichikawa, K., Keith, C. T., Lane, W. S., & Schreiber, S. L. (1994) · Nature · doi:10.1038/369756a0 · Cited by 2,053
Activation of a metabolic gene regulatory network downstream of mTOR complex 1
Düvel, K., Yecies, J. L., Menon, S., Raman, P., Lipovsky, A. I., Souza, A. L., Triantafellow, E., Ma, Q., Gorski, R., Cleaver, S., et al. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.06.022 · Cited by 2,020 · cited 1×
“55 Conversely, the mTORC2 pathway seems Figure 1 Adenosine monophosphate-activated protein kinase (AMPK).”
BackgroundMechanisms and disease consequences of nonalcoholic fatty liver disease
Loomba, R., Friedman, S. L., & Shulman, G. I. (2021) · Cell · doi:10.1016/j.cell.2021.04.015 · Cited by 2,002 · cited 1×
“10 NASH shows ER stress, oxidative stress (OS), mitochondrial damage, increased fi brogenesis, and disturbance of the gut fl ora, among other factors.”
BackgroundXiao, G., Zhu, S., Xiao, X., Yan, L., Yang, J., & Wu, G. (2017) · Hepatology · doi:10.1002/hep.29302 · Cited by 895
Luen Tang, B. (2016) · Molecules and Cells · doi:10.14348/molcells.2016.2318 · Cited by 740
Causes, Characteristics, and Consequences of Metabolically Unhealthy Normal Weight in Humans
Stefan, N., Schick, F., & Häring, H.-U. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.07.008 · Cited by 575
Tanaka, S., Hikita, H., Tatsumi, T., Sakamori, R., Nozaki, Y., Sakane, S., Shiode, Y., Nakabori, T., Saito, Y., Hiramatsu, N., et al. (2016) · Hepatology · doi:10.1002/hep.28820 · Cited by 376
Liver regeneration and inflammation: from fundamental science to clinical applications
Campana, L., Esser, H., Huch, M., & Forbes, S. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00373-7 · Cited by 307 · cited 1×
“11 Notably, among chronic liver diseases, NAFLD is associated with obesity, affects almost a quarter of the world ’ s population, and can progress to cirrhosis and HCC. 12 Re-markably, metabolic diseases induced by excessive consumption of nutrients are growing threats, leading to obesity, insulin…”
BackgroundIntegrative proteogenomic characterization of hepatocellular carcinoma across etiologies and stages
Ng, C. K. Y., Dazert, E., Boldanova, T., Coto-Llerena, M., Nuciforo, S., Ercan, C., Suslov, A., Meier, M.-A., Bock, T., Schmidt, A., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29960-8 · Cited by 165 · cited 1×
“74,75”
Research works printed but not linked: 63
- 10.1002/hep.31420 · DOI · Paper page
- 10.1097/hc9.0000000000000112 · DOI
- 10.1001/jama.2015.5370 · DOI · Paper page
- 10.1146/annurev‐nutr‐062220‐105200 · DOI · Paper page
- 10.1016/j.plefa.2018.11.005 · DOI
- 10.1038/nrdp.2015.80 · DOI · Paper page
- 10.1590/1414‐431X2021e11391 · DOI
- 10.1038/s41591‐018‐0104‐9 · DOI · Paper page
- 10.2174/1381612811319290006 · DOI · Paper page
- 10.1371/journal.pone.0146675 · DOI
- 10.1097/MEG.0000000000001235 · DOI
- 10.1007/s00428‐011‐1147‐1 · DOI
- 10.4067/s0717‐95022017000401482 · DOI
- 10.1007/978‐1‐60327‐345‐9_17 · doi:10.1007/978-1-60327-345-9_17
- 10.1016/j.livres.2020.02.004 · DOI
- 10.1016/j.clinre.2022.101922 · DOI
- 10.1146/annurev‐pharmtox‐010611‐134537 · DOI · Paper page
- 10.1111/j.1432‐1033.1991.tb16172.x · DOI · Paper page
- 10.1038/sj.onc.1204091 · DOI · Paper page
- 10.1155/2021/6655599 · DOI
- 10.1111/1750‐3841.14723 · DOI
- 10.1021/acs.jafc.0c07342 · DOI
- 10.1016/j.bbagrm.2016.03.002 · DOI · Paper page
- 10.3748/wjg.v27.i25.3837 · DOI · Paper page
- 10.1016/j.micpath.2018.03.021 · DOI
- 10.1016/j.canlet.2017.06.029 · DOI
- 10.1002/path.2697 · DOI · Paper page
- 10.1371/journal.pone.0165417 · DOI
- 10.1016/j.celrep.2017.04.042 · DOI · Paper page
- 10.1007/s00109‐021‐02117‐8 · DOI
- 10.1371/journal.pbio.3001522 · DOI
- 10.1152/physrev.00026.2020 · DOI · Paper page
- 10.1016/s0960‐9822(02)01077‐1 · DOI · Paper page
- 10.1152/ajpendo.00225.2016 · DOI · Paper page
- 10.1016/j.lfs.2021.119424 · DOI
- 10.1016/j.cellsig.2013.06.007 · DOI · Paper page
- 10.3390/ijms21062061 · DOI · Paper page
- 10.2337/db20‐0619 · DOI
- 10.1002/hep.32066 · DOI · Paper page
- 10.3390/cells9040837 · DOI · Paper page
- 10.3389/fcell.2021.655731 · DOI · Paper page
- 10.1016/j.celrep.2019.07.084 · DOI · Paper page
- 10.1007/s13238‐017‐0409‐3 · DOI · Paper page
- 10.1038/s42255‐021‐00440‐5 · DOI
- 10.1016/j.mam.2016.11.008 · DOI
- 10.1038/ncomms11365 · DOI · Paper page
- 10.1016/j.molcel.2017.05.030 · DOI · Paper page
- 10.1152/ajpendo.00660.2011 · DOI · Paper page
- 10.18632/oncotarget.3044 · DOI
- 10.1080/15384101.2016.1151581 · DOI · Paper page
- 10.1016/j.mam.2021.100973 · DOI · Paper page
- 10.1152/ajpgi.00451.2010 · DOI
- 10.3350/cmh.2020.0169 · DOI · Paper page
- 10.1080/15548627.2021.1895658 · DOI · Paper page
- 10.1002/jcp.29727 · DOI · Paper page
- 10.1083/jcb.201711002 · DOI · Paper page
- 10.4103/1673‐5374.340406 · DOI
- 10.1016/j.biochi.2021.11.008 · DOI · Paper page
- 10.1016/j.intimp.2016.11.015 · DOI
- 10.1007/s12011‐022‐03438‐6 · DOI
- 10.1248/bpb.b17‐00724 · DOI · Paper page
- 10.1038/s41366‐021‐00955‐7 · DOI
- 10.1158/0008‐5472.CAN‐21‐1259 · DOI
Cited by
Varghese, S., Rao, S., Khattak, A., Zamir, F., & Chaari, A. (2024) · Nutrients · doi:10.3390/nu16213663 · Cited by 152
Truong, X. T., & Lee, D. H. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2025.0644 · Cited by 84
The Crosstalk between Mesenchymal Stromal/Stem Cells and Hepatocytes in Homeostasis and under Stress
Kholodenko, I. V., Kholodenko, R. V., & Yarygin, K. N. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015212 · Cited by 16
Metadata
- Authors
- Marcondes‐de‐Castro, I. A., Reis‐Barbosa, P. H., Marinho, T. S., Aguila, M. B., & Mandarim‐de‐Lacerda, C. A.
- Venue
- Journal of Gastroenterology and Hepatology
- Publisher
- Wiley
- Published
- 2023-07-12
- Volume
- 38
- Issue
- 11
- Pages
- 1868-1876
- ISSN
- 0815-9319 (ISSN-L)
- 1440-1746
- OpenAlex
- W4384120487
- Cited by
- 102
- References
- 12
- FWCI
- 17.06
- Type
- journal article
- Language
- en
- Open access
- bronze
- Funders
- Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (E‐26/200.796/2021, E‐26/200.936/2021)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (305993/2021‐6)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (Finance code 001)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: AMPK/mTOR pathway significance in healthy liver and non‐alcoholic fatty liver disease and its progression. https://app.cochat.ai/papers/10.1111/jgh.16272
- The paper
- Marcondes‐de‐Castro, I. A., Reis‐Barbosa, P. H., Marinho, T. S., Aguila, M. B., & Mandarim‐de‐Lacerda, C. A. (2023). AMPK/mTOR pathway significance in healthy liver and non‐alcoholic fatty liver disease and its progression. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.16272
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.